...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Eligibility for registered accounts in Canada

I post that info a couple of days ago here and here, including the info from the pdf that no longer links.

Share
New Message
Please login to post a reply